-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
European Biotech Acquisition Corp. quarterly/annual Operating Income (Loss) history and growth rate from 2021 to 2022.
- European Biotech Acquisition Corp. Operating Income (Loss) for the quarter ending December 31, 2022 was -$1.17M, a 115% decline year-over-year.
- European Biotech Acquisition Corp. Operating Income (Loss) for the twelve months ending December 31, 2022 was -$2.82M, a 156% decline year-over-year.
- European Biotech Acquisition Corp. annual Operating Income (Loss) for 2022 was -$2.82M, a 156% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)